The FDA has been trying to mend fences with rare disease drug developers and patient groups since the departure of former Commissioner Marty Makary three months ago. But advisory committee meetings ...

Olivia Rinaldi is a White House reporter at CBS News. She covered President Trump's 2024 presidential campaign and was ...

High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.

Scott Gottlieb, the former commissioner of the Food and Drug Administration (FDA), said Sunday the agency does not yet have the outbreak of cyclosporiasis under control. “I don’t think it’s under ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Sign up for Inside the Trump Presidency, a newsletter featuring coverage of the second Trump term. The world’s most popular podcaster, Joe Rogan, reached out ...

Engelbert sent a memo to teams saying the topic will be discussed at an already scheduled meeting. WNBA Commissioner Cathy Engelbert has sent a memo to teams that addresses ongoing discussions around ...

The commissioner met virtually with players to discuss officiating, security and online harassment. “The biggest thing was communication,” Chicago Sky center Elizabeth Williams said. David Dow / Getty ...

A select number of allergy medications have been voluntarily recalled after cross-contamination with a drug used for heartburn and severe acid reflux. A select number of allergy medications have been ...

Marty Makary resigned as FDA commissioner amid controversy. But his reforms to drug review times and AI are the agency's ...

Add Yahoo as a preferred source to see more of our stories on Google. WASHINGTON, DC - APRIL 22: Food and Drug Administration Commissioner Marty Makary speaks during a news conference at the Health ...